Cargando…
Modeling drug resistance in a conjoint normal-tumor setting
BACKGROUND: In this paper, we modify our previously developed conjoint tumor-normal cell model in order to make a distinction between tumor cells that are responsive to chemotherapy and those that may show resistance. RESULTS: Using this newly developed core model, the evolution of three cell types:...
Autores principales: | Feizabadi, Mitra Shojania, Witten, Tarynn M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429337/ https://www.ncbi.nlm.nih.gov/pubmed/25588472 http://dx.doi.org/10.1186/1742-4682-12-3 |
Ejemplares similares
-
Modeling the Effects of a Simple Immune System and Immunodeficiency on the Dynamics of Conjointly Growing Tumor and Normal Cells
por: Feizabadi, Mitra Shojania, et al.
Publicado: (2011) -
Chemotherapy in conjoint aging-tumor systems: some simple models for addressing coupled aging-cancer dynamics
por: Feizabadi, Mitra S, et al.
Publicado: (2010) -
Modeling multi-mutation and drug resistance: analysis of some case studies
por: Feizabadi, Mitra Shojania
Publicado: (2017) -
The Effect of Tau and Taxol on Polymerization of MCF7 Microtubules In Vitro
por: Feizabadi, Mitra Shojania, et al.
Publicado: (2022) -
The Conjoint Course
Publicado: (1907)